Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.
Thangavel, Chellappagounder
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. [electronic resource] - Endocrine-related cancer Jun 2011 - 333-45 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1479-6821
10.1530/ERC-10-0262 doi
Breast Neoplasms--drug therapy
Cell Cycle--drug effects
Cell Line, Tumor
Cyclin D1--biosynthesis
Female
Gene Expression Profiling
Humans
Molecular Targeted Therapy
Neoplasms, Hormone-Dependent--drug therapy
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Pyridines--pharmacology
RNA, Messenger--biosynthesis
Receptors, Estrogen--antagonists & inhibitors
Retinoblastoma Protein--metabolism
Reverse Transcriptase Polymerase Chain Reaction
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. [electronic resource] - Endocrine-related cancer Jun 2011 - 333-45 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1479-6821
10.1530/ERC-10-0262 doi
Breast Neoplasms--drug therapy
Cell Cycle--drug effects
Cell Line, Tumor
Cyclin D1--biosynthesis
Female
Gene Expression Profiling
Humans
Molecular Targeted Therapy
Neoplasms, Hormone-Dependent--drug therapy
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Pyridines--pharmacology
RNA, Messenger--biosynthesis
Receptors, Estrogen--antagonists & inhibitors
Retinoblastoma Protein--metabolism
Reverse Transcriptase Polymerase Chain Reaction